Clinical and Biological Characteristics of Hidradenitis Suppurativa
ConditionHidradenitis Suppurativa
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age13+
SponsorUniversity of California, San Francisco
About this trial
Hidradenitis suppurativa (HS) is a common and debilitating skin disease that is poorly understood and understudied. As a result, little is known about disease prognosis and few effective treatments exist for this condition. This prospective observational cohort study aims to comprehensively characterize the clinical and biological features of HS. The results of this research will provide a basis for the development of an HS clinical classification system and identification of potential treatments for HS.
Eligibility criteria
Qualifiers
Age 13 years or older
Diagnosis of HS clinically-confirmed by a physician
Disqualifiers
No history of chronic skin conditions
No recent history of antibiotic use
Trial design
Treatments tested in this trial
- Not listed
Trial groups
1,000 Participants
are grouped into 2 trial groupsSponsors and collaborators
Source ClinicalTrials.gov